慢性肾脏病中的炎症性与心血管事件:动脉粥样硬化多种族研究(MESA)
基于MESA多中心人群队列中6705名无心血管病参与者,按改良KDIGO分组评估基线CKD分级与慢性炎症相关疾病(ChrIRD)、心血管事件及全因死亡的关系。随访19年发现ChrIRD发生率随CKD风险分级升高呈梯度增加,从尿白蛋白肌酐比>10 mg/g即开始,且在多数肾功能阶段超过心血管疾病风险。
要点
- 随访19年,ChrIRD与心血管事件未调整发生率均随CKD风险分级升高而递增。
- 低风险CKD即与ChrIRD风险升高相关(HR 1.23,95%CI 1.10-1.39)。
- 极高风险CKD的ChrIRD风险HR达3.87(95%CI 2.75-5.44)。
核心结论
- ChrIRD随CKD风险分级恶化呈梯度增加,从尿白蛋白肌酐比>10 mg/g即开始显现。
- 在多数肾功能阶段,ChrIRD风险超过心血管疾病风险。
研究设计与样本
- 纵向观察性研究,随访19年。
- 参与者来自动脉粥样硬化多种族研究(MESA),为多中心、基于人群的队列,纳入无心血管病者。
- 共纳入6705名参与者,平均年龄62岁,53%女性,38.5%白人,27.6%黑人,22%西班牙裔,11.9%华人。
- 暴露为基于改良KDIGO分组的基线5级CKD分类,依据估算肾小球滤过率(eGFR,mL/min/1.73m2)和尿白蛋白肌酐比(UACR,mg/g)。
- 结局为首次ChrIRD时间、首次心血管事件时间和全因死亡时间;ChrIRD为通过国际疾病分类编码(除外肾脏编码)识别的炎症或感染性疾病。
主要发现
- 研究参与者中70%无CKD,17%为低风险CKD(eGFR>60且UACR 10-29),7%为中风险CKD(eGFR≥60且UACR 30-299),4.6%为高风险CKD(eGFR 30-59且UACR<30,或eGFR 45-59且UACR 30-299,或eGFR≥60且UACR≥300),0.8%为极高风险CKD(更晚期的eGFR/UACR组合)。
- 随访19年,无CKD、低风险CKD、中风险CKD、高风险CKD和极高风险CKD的ChrIRD未调整发生率分别为每1000人年18、26.3、39.7、60.1和128.7次事件。
- 随访19年,无CKD、低风险CKD、中风险CKD、高风险CKD和极高风险CKD的心血管事件未调整发生率分别为每1000人年11.9、18.4、29.6、35.4和56.6次事件。
- 人口学调整后,低风险CKD的ChrIRD风险HR为1.23(95%CI 1.10-1.39),极高风险CKD的ChrIRD风险HR为3.87(95%CI 2.75-5.44)。
- 人口学调整后,低风险CKD的心血管事件风险HR为1.35(95%CI 1.17-1.55),极高风险CKD的心血管事件风险HR为2.84(95%CI 1.85-4.36)。
临床怎么用
- 作者认为,本研究强调随着肾功能恶化,应识别感染性和非感染性炎症性疾病的重要性。
- 作者建议,未来研究应聚焦于进一步理解该关联并减轻风险的方法。
局限性
- 存在未测量的混杂因素。
- 存在选择偏倚。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
RATIONALE & OBJECTIVE: Chronic kidney disease (CKD) is associated with a proinflammatory state caused by maladaptive immune response, predisposing individuals to cardiovascular (CVD) and inflammatory/infectious disease outcomes. We sought to examine the association of chronic inflammation-related disease (ChrIRD) as compared with CVD events with worsening kidney function. STUDY DESIGN: Longitudinal, observational study over 19 years of follow-up. SETTING & PARTICIPANTS: Participants free of CVD were enrolled from the Multi-Ethnic Study of Atherosclerosis (MESA), a multicenter, population-based cohort. EXPOSURE: Baseline 5-level CKD categories based on modified KDIGO (Kidney Disease Improving Global Outcomes) groups using estimated glomerular filtration rate (eGFR, mL/min/1.73m2) and urinary albumin-creatinine ratio (UACR, mg/g). OUTCOME: Three outcomes of interest: time to occurrence of first ChrIRD, time to first CVD, and time to all-cause mortality. ChrIRD encompassed inflammatory or infectious conditions identified using International Classification of Diseases codes (except kidney codes). ANALYTICAL APPROACH: Proportional hazards regression analysis. RESULTS: The study included 6,705 participants (mean age 62 years, 53% female, 38.5% White, 27.6% Black, 22% Hispanic, 11.9% Chinese). Among the study participants, 70% had no CKD, 17% had low-risk CKD (eGFR >60+UACR10-29); 7% had moderate-risk CKD (eGFR≥60+UACR 30-299), 4.6% had high-risk CKD (eGFR 30-59+UACR<30 or eGFR 45-59+UACR 30-299 or eGFR≥60 and UACR≥300), and 0.8% had very high-risk CKD (more advanced combinations of eGFR/UACR). Over 19 years of follow-up, the unadjusted incidence density (events/1,000-person-years) of ChrIRD and CVD events, respectively, was 18 and 11.9 for no CKD, 26.3 and 18.4 for low-risk CKD, 39.7 and 29.6 for moderate-risk CKD, 60.1 and 35.4 for high-risk CKD, and 128.7 and 56.6 for very high-risk CKD. After demographic adjustment, the respective hazard ratios for ChrIRD and CVD events were 1.23 (95% CI, 1.10-1.39) and 1.35 (95% CI, 1.17-1.55) for low-risk CKD, generally increasing to 3.87 (95% CI, 2.75-5.44) and 2.84 (95% CI, 1.85-4.36) for very high-risk CKD categories. LIMITATIONS: Unmeasured confounders and selection bias. CONCLUSIONS: ChrIRD increased in a graded fashion with worsening CKD risk categories, starting with UACR >10mg/g. PLAIN-LANGUAGE SUMMARY: In this observational study, we used a large community-based sample from the Multi-Ethnic Study of Atherosclerosis to evaluate the likelihood of, and risks associated with, inflammatory conditions with worsening kidney function. We studied a novel diagnostic entity called chronic inflammation-related disease (ChrIRD) encompassing several infectious and noninfectious inflammatory conditions. Over 19 years of follow-up, we demonstrated progressively higher risk of ChrIRD with worsening kidney function. The risks of ChrIRD are apparent in individuals with low levels of proteinuria and exceed cardiovascular disease at most stages of kidney function. This study highlights the importance of recognizing both infectious and noninfectious inflammatory conditions with worsening kidney function. Future studies should focus on ways to further understand this association and mitigate the risks.
引用
- Shroff GR, Duprez DA, Manning E, et al. Inflammatory and Cardiovascular Events in CKD: The Multi-Ethnic Study of Atherosclerosis (MESA). Am J Kidney Dis. 2025. PMID: 40381932. doi:10.1053/j.ajkd.2025.03.020
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。